These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36472287)
1. CHANGES IN PROSTAGLANDIN LEVELS IN BLOOD SERUM OF PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE ON THE BACKGROUND OF THE OSTEOCHONDROSIS OF THE SPINE AND OBESITY. Sirchak YS; Boldizhar OO; Filak YF; Ustych OV; Koval VY; Barani VY; Borisova IS Wiad Lek; 2022; 75(10):2497-2500. PubMed ID: 36472287 [TBL] [Abstract][Full Text] [Related]
2. CHANGES IN SERUM GHRELIN AND ITS RELATIONSHIP WITH OF BODY MASS INDEX IN PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE AND SPONDYLOARTHRITIS. Sirchak YS; Tsioka SA; Chobej AS; Bedey NV; Borisova IS Wiad Lek; 2022; 75(4 pt 2):982-986. PubMed ID: 35633329 [TBL] [Abstract][Full Text] [Related]
3. CHANGES IN SERUM SOMATOSTATIN AND GASTRIN LEVELS IN PATIENTS AFTER CHOLECYSTECTOMY AND GASTROESOPHAGEAL REFLUX DISEASE. Sirchak YS; Kydybyts SS; Bedey NV; Chendey VI; Stan MP; Chobej SM Wiad Lek; 2023; 76(3):548-553. PubMed ID: 37057778 [TBL] [Abstract][Full Text] [Related]
4. Alcohol Consumption and the Risk of Gastroesophageal Reflux Disease: A Systematic Review and Meta-analysis. Pan J; Cen L; Chen W; Yu C; Li Y; Shen Z Alcohol Alcohol; 2019 Jan; 54(1):62-69. PubMed ID: 30184159 [TBL] [Abstract][Full Text] [Related]
6. Changes in cholecystokinin level in patients with gastroesophageal reflux disease on the background of type II diabetes. Sirchak YS; Stan MP; Brych VV Wiad Lek; 2018; 71(2 pt 1):333-336. PubMed ID: 29729168 [TBL] [Abstract][Full Text] [Related]
7. Determination of prostacyclin in plasma through a bioluminescent immunoassay for 6-keto-prostaglandin F1alpha: implication of dosage in patients with primary pulmonary hypertension. Desai UA; Deo SK; Hyland KV; Poon M; Daunert S Anal Chem; 2002 Aug; 74(15):3892-8. PubMed ID: 12175181 [TBL] [Abstract][Full Text] [Related]
8. Different patterns of renal prostaglandins I2 and E2 in patients with essential hypertension with low to normal or high renin activity. Tsuji T; Yasu T; Katayama Y; Imanishi M J Hypertens; 2000 Aug; 18(8):1091-6. PubMed ID: 10954001 [TBL] [Abstract][Full Text] [Related]
9. Weight loss and waist reduction is associated with improvement in gastroesophageal disease reflux symptoms: A longitudinal study of 15 295 subjects undergoing health checkups. Park SK; Lee T; Yang HJ; Park JH; Sohn CI; Ryu S; Park DI Neurogastroenterol Motil; 2017 May; 29(5):. PubMed ID: 28002892 [TBL] [Abstract][Full Text] [Related]
10. [FEATURES MANIFESTATIONS COMORBID CURRENTS OF GASTROESOPHAGEAL REFLUX DISEASE AND ARTERIAL HYPERTENSION DEPENDING ON THE DEGREE OF ARTERIAL HYPERTENSION]. Fadieienko G; Gridniev O Georgian Med News; 2015 Nov; (248):21-9. PubMed ID: 26656546 [TBL] [Abstract][Full Text] [Related]
11. Effect of zinc deficiency on prostaglandin synthesis in different organs of the rat. Meydani SN; Dupont J J Nutr; 1982 Jun; 112(6):1098-104. PubMed ID: 7045297 [TBL] [Abstract][Full Text] [Related]
12. Gastroesophageal reflux disease and obesity: do we need to perform reflux testing in all candidates to bariatric surgery? Tolone S; Limongelli P; del Genio G; Brusciano L; Rossetti G; Amoroso V; Schettino P; Avellino M; Gili S; Docimo L Int J Surg; 2014; 12 Suppl 1():S173-7. PubMed ID: 24859401 [TBL] [Abstract][Full Text] [Related]
13. 24-h pH-metry and multichannel intraluminal impedance monitoring in obese patients with and without gastroesophageal reflux disease symptoms. Ricci G; Amella C; Forti E; Rossi A; Bersani G; Dari S; Pasini V; Maimone A; Alvisi V Obes Surg; 2011 Jan; 21(1):48-53. PubMed ID: 20835898 [TBL] [Abstract][Full Text] [Related]